United Therapeutics Corp (UTHR)
274.29
+2.07
(+0.76%)
USD |
NASDAQ |
May 17, 16:00
274.29
0.00 (0.00%)
After-Hours: 19:42
United Therapeutics Shareholders Equity (Quarterly): 5.338B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.338B |
December 31, 2023 | 5.985B |
September 30, 2023 | 5.712B |
June 30, 2023 | 5.411B |
March 31, 2023 | 5.123B |
December 31, 2022 | 4.797B |
September 30, 2022 | 4.562B |
June 30, 2022 | 4.318B |
March 31, 2022 | 4.176B |
December 31, 2021 | 3.959B |
September 30, 2021 | 3.830B |
June 30, 2021 | 3.640B |
March 31, 2021 | 3.445B |
December 31, 2020 | 3.395B |
September 30, 2020 | 3.283B |
June 30, 2020 | 3.094B |
March 31, 2020 | 2.948B |
December 31, 2019 | 2.780B |
September 30, 2019 | 2.716B |
June 30, 2019 | 2.567B |
March 31, 2019 | 2.338B |
December 31, 2018 | 2.808B |
September 30, 2018 | 2.712B |
June 30, 2018 | 2.585B |
March 31, 2018 | 2.389B |
Date | Value |
---|---|
December 31, 2017 | 2.121B |
September 30, 2017 | 2.089B |
June 30, 2017 | 1.795B |
March 31, 2017 | 2.076B |
December 31, 2016 | 1.862B |
September 30, 2016 | 1.850B |
June 30, 2016 | 1.817B |
March 31, 2016 | 1.723B |
December 31, 2015 | 1.600B |
September 30, 2015 | 1.479B |
June 30, 2015 | 1.054B |
March 31, 2015 | 1.112B |
December 31, 2014 | 1.266B |
September 30, 2014 | 1.217B |
June 30, 2014 | 1.213B |
March 31, 2014 | 1.358B |
December 31, 2013 | 1.304B |
September 30, 2013 | 1.308B |
June 30, 2013 | 1.216B |
March 31, 2013 | 1.162B |
December 31, 2012 | 1.095B |
September 30, 2012 | 1.061B |
June 30, 2012 | 1.010B |
March 31, 2012 | 1.025B |
December 31, 2011 | 959.37M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.567B
Minimum
Jun 2019
5.985B
Maximum
Dec 2023
4.054B
Average
3.894B
Median
Shareholders Equity (Quarterly) Benchmarks
Liquidia Corp | 86.26M |
Ligand Pharmaceuticals Inc | 806.52M |
Esperion Therapeutics Inc | -294.30M |
Vertex Pharmaceuticals Inc | 18.55B |
Heron Therapeutics Inc | -33.77M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.495B |
Total Liabilities (Quarterly) | 1.157B |
Debt to Equity Ratio | 0.1124 |
Current Ratio | 3.775 |
Net Debt Paydown Yield | 0.39% |